TCEAL5
gene geneOn this page
Also known as WEX4
Summary
TCEAL5 (transcription elongation factor A like 5, HGNC:22282) is a protein-coding gene on chromosome Xq22.1, encoding Transcription elongation factor A protein-like 5 (Q5H9L2). May be involved in transcriptional regulation.
This gene, which is located on the X chromosome, encodes a protein which contains a BEX (brain expressed X-liked like family) domain. This domain is found in proteins encoded by the TCEAL elongation factor (transcription elongation factor A (SII)-like) gene family also located on the X chromosome. The coding region for this gene is located entirely in the terminal exon.
Source: NCBI Gene 340543 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total
- MANE Select transcript:
NM_001012979
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22282 |
| Approved symbol | TCEAL5 |
| Name | transcription elongation factor A like 5 |
| Location | Xq22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | WEX4 |
| Ensembl gene | ENSG00000204065 |
| Ensembl biotype | protein_coding |
| OMIM | 301155 |
| Entrez | 340543 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 protein_coding
ENST00000372680, ENST00000909247, ENST00000909248, ENST00000909249, ENST00000911483, ENST00000911484, ENST00000911485, ENST00000911486, ENST00000911487, ENST00000911488
RefSeq mRNA: 1 — MANE Select: NM_001012979
NM_001012979
CCDS: CCDS35356
Canonical transcript exons
ENST00000372680 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001458378 | 103273691 | 103274590 |
| ENSE00001458379 | 103275275 | 103275342 |
| ENSE00001458380 | 103276673 | 103276750 |
Expression profiles
Bgee: expression breadth ubiquitous, 122 present calls, max score 97.54.
FANTOM5 (CAGE): breadth broad, TPM avg 10.6800 / max 4119.4873, expressed in 291 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199986 | 6.7252 | 263 |
| 199987 | 1.9777 | 235 |
| 199988 | 1.5577 | 224 |
| 199985 | 0.3980 | 87 |
| 199989 | 0.0213 | 10 |
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| superior frontal gyrus | UBERON:0002661 | 97.54 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 96.97 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.92 | gold quality |
| cerebellum | UBERON:0002037 | 96.89 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.89 | gold quality |
| nucleus accumbens | UBERON:0001882 | 96.87 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.78 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.73 | gold quality |
| hypothalamus | UBERON:0001898 | 96.72 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.72 | gold quality |
| frontal cortex | UBERON:0001870 | 96.65 | gold quality |
| primary visual cortex | UBERON:0002436 | 96.53 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.46 | gold quality |
| cerebral cortex | UBERON:0000956 | 96.41 | gold quality |
| putamen | UBERON:0001874 | 96.18 | gold quality |
| brain | UBERON:0000955 | 96.07 | gold quality |
| caudate nucleus | UBERON:0001873 | 96.00 | gold quality |
| amygdala | UBERON:0001876 | 95.88 | gold quality |
| temporal lobe | UBERON:0001871 | 95.85 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.79 | gold quality |
| Ammon’s horn | UBERON:0001954 | 95.58 | gold quality |
| right testis | UBERON:0004534 | 95.57 | gold quality |
| pituitary gland | UBERON:0000007 | 95.43 | gold quality |
| left testis | UBERON:0004533 | 95.09 | gold quality |
| testis | UBERON:0000473 | 95.06 | gold quality |
| cortical plate | UBERON:0005343 | 94.34 | gold quality |
| substantia nigra | UBERON:0002038 | 93.66 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.18 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 36.65 |
| E-GEOD-84465 | yes | 6.88 |
| E-ANND-3 | no | 2.97 |
| E-GEOD-83139 | no | 2.94 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting TCEAL5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-133A-5P | 99.28 | 69.13 | 941 |
| HSA-MIR-4717-3P | 99.06 | 66.34 | 1072 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-4763-5P | 98.75 | 63.89 | 854 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-4490 | 98.51 | 68.47 | 943 |
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
| HSA-MIR-4701-3P | 98.17 | 66.25 | 788 |
| HSA-MIR-6736-5P | 98.17 | 66.43 | 760 |
| HSA-MIR-93-3P | 98.15 | 66.65 | 1309 |
| HSA-MIR-6131 | 97.22 | 66.72 | 960 |
| HSA-MIR-6872-3P | 97.08 | 66.99 | 750 |
| HSA-MIR-6894-3P | 96.73 | 65.64 | 798 |
| HSA-MIR-1236-5P | 96.62 | 66.38 | 856 |
| HSA-MIR-152-5P | 96.42 | 66.59 | 960 |
| HSA-MIR-4509 | 96.19 | 65.80 | 900 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tceal6 | ENSMUSG00000031409 |
| mus_musculus | Tceal3 | ENSMUSG00000044550 |
| mus_musculus | Tceal5 | ENSMUSG00000054034 |
| rattus_norvegicus | Tceal5 | ENSRNOG00000046280 |
| rattus_norvegicus | Tceal6 | ENSRNOG00000046390 |
| rattus_norvegicus | Tceal3 | ENSRNOG00000049020 |
Paralogs (8): TCEAL4 (ENSG00000133142), TCEAL1 (ENSG00000172465), TCEAL8 (ENSG00000180964), TCEAL7 (ENSG00000182916), TCEAL2 (ENSG00000184905), TCEAL9 (ENSG00000185222), TCEAL3 (ENSG00000196507), TCEAL6 (ENSG00000204071)
Protein
Protein identifiers
Transcription elongation factor A protein-like 5 — Q5H9L2 (reviewed: Q5H9L2)
Alternative names: Transcription elongation factor S-II protein-like 5
All UniProt accessions (1): Q5H9L2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the TFS-II family. TFA subfamily.
RefSeq proteins (1): NP_001012997* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021156 | TF_A-like/BEX | Family |
Pfam: PF04538
UniProt features (10 total): compositionally biased region 8, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5H9L2-F1 | 58.48 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
GSE13522_WT_VS_IFNG_KO_SKIN_DN, CHEN_METABOLIC_SYNDROM_NETWORK, chrXq22, YANG_BCL3_TARGETS_UP, MIR6835_3P, MIR3919, MIR5589_3P, MIR5581_3P, MIR3692_5P, MIR133A_5P, MIR152_5P, MANNO_MIDBRAIN_NEUROTYPES_HDA, MANNO_MIDBRAIN_NEUROTYPES_HDA2, MANNO_MIDBRAIN_NEUROTYPES_HGABA, MANNO_MIDBRAIN_NEUROTYPES_HOMTN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1228 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TCEAL5 | TCEAL8 | Q8IYN2 | 678 |
| TCEAL5 | BEX1 | Q9HBH7 | 644 |
| TCEAL5 | BEX5 | Q5H9J7 | 588 |
| TCEAL5 | TCEAL7 | Q9BRU2 | 578 |
| TCEAL5 | TCEAL9 | Q9UHQ7 | 545 |
| TCEAL5 | TCEAL1 | Q15170 | 537 |
| TCEAL5 | BEX2 | Q9BXY8 | 520 |
| TCEAL5 | BEX3 | Q00994 | 467 |
| TCEAL5 | RAB40C | Q96S21 | 394 |
| TCEAL5 | RAB40A | Q8WXH6 | 392 |
| TCEAL5 | RAB40B | Q12829 | 390 |
| TCEAL5 | CHAMP1 | Q96JM3 | 339 |
| TCEAL5 | MEA1 | Q16626 | 329 |
| TCEAL5 | FAM162B | Q5T6X4 | 323 |
| TCEAL5 | ARMCX4 | Q5H9R4 | 322 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BCL2L1 | BCL2L11 | psi-mi:“MI:0914”(association) | 0.870 |
| NR4A2 | TCEAL5 | psi-mi:“MI:0915”(physical association) | 0.520 |
| ZNF74 | GAPDHS | psi-mi:“MI:0914”(association) | 0.350 |
| TCEAL5 | C3orf38 | psi-mi:“MI:0914”(association) | 0.350 |
| TCEAL5 | NR4A2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DEDD | TCEAL5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HNF1A | TCEAL5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRKAR1A | TCEAL5 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): KLHL8 (Affinity Capture-MS), C3orf38 (Affinity Capture-MS), TCEAL3 (Affinity Capture-MS), USP7 (Affinity Capture-MS), TCEAL5 (Affinity Capture-MS), TCEAL5 (Cross-Linking-MS (XL-MS)), TCEAL5 (Cross-Linking-MS (XL-MS)), TCEAL5 (Cross-Linking-MS (XL-MS)), TCEAL5 (Cross-Linking-MS (XL-MS)), TCEAL3 (Cross-Linking-MS (XL-MS)), TCEAL5 (Reconstituted Complex)
ESM2 similar proteins: A0A8I5ZN27, A2TJV2, A4FU49, A8MU46, E1AZ71, E9Q9K5, O54963, P10636, P10637, P19332, P36225, P82179, Q13127, Q28139, Q28181, Q29026, Q2EI20, Q4R729, Q5FVI4, Q5H9L2, Q5S6V2, Q5SRN2, Q5STT6, Q5TGJ6, Q5YCV9, Q5YCW0, Q5YCW1, Q62313, Q62314, Q63803, Q640N3, Q6IPX3, Q6P6B1, Q7Z6I6, Q811Q2, Q8BHB9, Q8CCT4, Q8K0S2, Q8N111, Q8R0A5
Diamond homologs: Q5H9L2, Q5R6B4, Q6IPX3, Q8CCT4, Q8R0A5, Q969E4, Q96EI5, Q9H3H9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
627 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:103274586:CTTTC:C | acceptor_gain | 1.0000 |
| X:103274591:C:CA | acceptor_loss | 1.0000 |
| X:103274591:C:CC | acceptor_gain | 1.0000 |
| X:103275272:GACCT:G | donor_loss | 1.0000 |
| X:103275273:A:T | donor_loss | 1.0000 |
| X:103275274:C:A | donor_loss | 1.0000 |
| X:103275297:T:TA | donor_gain | 1.0000 |
| X:103275343:C:CA | acceptor_loss | 1.0000 |
| X:103275343:C:CC | acceptor_gain | 1.0000 |
| X:103275344:T:C | acceptor_loss | 1.0000 |
| X:103274587:TTTC:T | acceptor_gain | 0.9900 |
| X:103274588:TTC:T | acceptor_gain | 0.9900 |
| X:103274589:TC:T | acceptor_gain | 0.9900 |
| X:103274590:CC:C | acceptor_gain | 0.9900 |
| X:103274599:C:CT | acceptor_gain | 0.9900 |
| X:103274600:A:T | acceptor_gain | 0.9900 |
| X:103275339:AGAC:A | acceptor_gain | 0.9900 |
| X:103275340:GAC:G | acceptor_gain | 0.9900 |
| X:103275341:AC:A | acceptor_gain | 0.9900 |
| X:103275342:CC:C | acceptor_gain | 0.9900 |
| X:103275346:C:CT | acceptor_gain | 0.9900 |
| X:103275347:A:T | acceptor_gain | 0.9900 |
| X:103276668:CCGA:C | donor_loss | 0.9900 |
| X:103276670:GA:G | donor_loss | 0.9900 |
| X:103276671:AC:A | donor_loss | 0.9900 |
| X:103276672:C:CT | donor_loss | 0.9900 |
| X:103274591:C:T | acceptor_gain | 0.9800 |
| X:103275274:CCT:C | donor_gain | 0.9800 |
| X:103275276:TGC:T | donor_gain | 0.9800 |
| X:103275338:AAGAC:A | acceptor_gain | 0.9800 |
AlphaMissense
1370 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:103274213:T:A | K117N | 0.973 |
| X:103274213:T:G | K117N | 0.973 |
| X:103274207:T:A | K119N | 0.964 |
| X:103274207:T:G | K119N | 0.964 |
| X:103274219:T:A | K115N | 0.962 |
| X:103274219:T:G | K115N | 0.962 |
| X:103274210:T:A | R118S | 0.960 |
| X:103274210:T:G | R118S | 0.960 |
| X:103274208:T:A | K119I | 0.951 |
| X:103274220:T:A | K115I | 0.939 |
| X:103274208:T:G | K119T | 0.931 |
| X:103274214:T:A | K117I | 0.929 |
| X:103274205:G:A | T120I | 0.909 |
| X:103274209:T:C | K119E | 0.907 |
| X:103274214:T:G | K117T | 0.907 |
| X:103274000:C:A | R188S | 0.905 |
| X:103274000:C:G | R188S | 0.905 |
| X:103274220:T:G | K115T | 0.897 |
| X:103274198:C:A | R122S | 0.895 |
| X:103274198:C:G | R122S | 0.895 |
| X:103274226:G:T | P113H | 0.894 |
| X:103274221:T:C | K115E | 0.883 |
| X:103274081:T:A | K161N | 0.878 |
| X:103274081:T:G | K161N | 0.878 |
| X:103274060:A:C | F168L | 0.877 |
| X:103274060:A:T | F168L | 0.877 |
| X:103274062:A:G | F168L | 0.877 |
| X:103273991:C:A | R191S | 0.876 |
| X:103273991:C:G | R191S | 0.876 |
| X:103274211:C:G | R118T | 0.872 |
dbSNP variants (sampled 300 via entrez): RS1000146119 (X:103274871 A>G), RS1002614609 (X:103277747 T>A,C), RS1003618018 (X:103275571 G>A), RS1003808938 (X:103276344 G>A), RS1005868285 (X:103278162 C>A,G), RS1006081186 (X:103276568 A>G), RS1007067212 (X:103277577 C>T), RS1007183260 (X:103277044 A>T), RS1007553831 (X:103277977 C>T), RS1007581645 (X:103277434 T>C), RS1007915203 (X:103275327 C>T), RS1010599534 (X:103276025 C>T), RS1011165566 (X:103277323 C>T), RS1011366923 (X:103276942 G>A), RS1011863410 (X:103278251 G>T)
Disease associations
OMIM: gene MIM:301155 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | increases methylation | 1 |
| Benzo(a)pyrene | decreases methylation, affects methylation | 1 |
| Potassium Dichromate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.